Trulieve Cannabis (TRLV) Earnings
Trulieve Cannabis reported on November 5, 2026: EPS of 0.09 against 0.09 expected, in line.
Summary
In the quarter ended September 2026, Trulieve Cannabis had revenue of $230M, down 20.1% on a year earlier, and diluted EPS of 0.00.
Report dates
| Report | Date | Time | EPS estimate | EPS reported | Result |
|---|---|---|---|---|---|
| Last | Thu Nov 5, 2026 | — | 0.09 | 0.09 | In line |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Also reporting the week of November 2
| Company | Date | Time |
|---|---|---|
| Apple Inc AAPL | Mon Nov 2 | Reported |
| Advanced Micro Devices Inc AMD | Tue Nov 3 | Reported |
| Palantir Technologies Inc. PLTR | Mon Nov 2 | Reported |
| Toyota Motor Corporation ADR TM | Wed Nov 4 | Reported |
| Amgen Inc AMGN | Tue Nov 3 | Reported |
| Arista Networks ANET | Tue Nov 3 | Reported |
| McDonald’s Corporation MCD | Wed Nov 4 | Reported |
| Shopify Inc SHOP | Tue Nov 3 | Reported |
Quarterly results
The last 12 quarters from Trulieve Cannabis's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | $230M | -20.1% | 0.00 | — | 18.5% | 2026-11-05 |
| Jun 30, 2026 | $271M | -10.3% | — | — | -136.7% | 2026-08-07 |
| Mar 31, 2026 | $287M | -3.7% | — | — | 12.5% | 2026-05-07 |
| Dec 31, 2025 | $293M | -2.7% | — | — | 5.2% | 2026-02-26 |
| Sep 30, 2025 | $288M | +1.4% | -0.14 | — | 14.7% | 2025-11-05 |
| Jun 30, 2025 | $302M | -0.4% | — | — | 17.4% | 2025-08-06 |
| Mar 31, 2025 | $298M | +0.0% | -0.16 | — | 11.2% | 2025-05-07 |
| Dec 31, 2024 | $301M | +4.9% | — | — | 0.4% | 2025-02-27 |
| Sep 30, 2024 | $284M | +3.3% | -0.32 | — | 0.2% | 2024-11-05 |
| Jun 30, 2024 | $303M | +7.7% | -0.04 | — | 16.4% | 2024-08-06 |
| Mar 31, 2024 | $298M | +4.3% | -0.16 | — | 15.5% | 2024-05-09 |
| Dec 31, 2023 | $287M | -3.9% | — | — | 10.2% | 2024-02-29 |
Questions about Trulieve Cannabis
Did Trulieve Cannabis beat earnings estimates?
In its report on November 5, 2026, Trulieve Cannabis matched the EPS estimate: 0.09 reported against 0.09 expected.
How did Trulieve Cannabis do last quarter?
In the quarter ended September 2026, Trulieve Cannabis had revenue of $230M, down 20.1% on a year earlier, and diluted EPS of 0.00.
From Trulieve Cannabis's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.